Rajesh K. Malik

Chief Tech/Sci/R&D Officer at G1 THERAPEUTICS, INC.

Net worth: 259 824 $ as of 2024-04-29

65 year

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Stephen V. Frye	M	-	Meryx, Inc. Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC.	17 years
Jack Bailey	M	59	G1 THERAPEUTICS, INC.	4 years
Norman Sharpless	M	57	G1 THERAPEUTICS, INC.	10 years
Garry Nicholson	M	69	G1 THERAPEUTICS, INC.	6 years
Monica Thomas	F	-	G1 THERAPEUTICS, INC.	1 years
Glenn Muir	M	65	G1 THERAPEUTICS, INC.	9 years
Michael Thompson	M	-	POIT BIOP	1 years
Jacks Lee	M	60	G1 THERAPEUTICS, INC.	2 years
H. Shelton Earp	M	-	Meryx, Inc. Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC.	17 years
Douglas K. Graham	M	-	Meryx, Inc. Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC.	17 years
Terry Murdock	M	64	G1 THERAPEUTICS, INC.	7 years
Alicia Secor	F	62	G1 THERAPEUTICS, INC.	3 years
Philip Johnson	M	59	POIT BIOP	1 years
Sailash I. Patel	M	-	Meryx, Inc. Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC.	-
Cynthia Flowers	F	64	G1 THERAPEUTICS, INC.	6 years
William C. Roberts	M	54	G1 THERAPEUTICS, INC.	3 years
Andrew Beelen	M	-	G1 THERAPEUTICS, INC.	-
John Umstead	M	-	G1 THERAPEUTICS, INC.	6 years
Mark Avagliano	M	48	G1 THERAPEUTICS, INC.	5 years
Gordon Brooks	M	-	POIT BIOP	1 years
Andrew Perry	M	51	G1 THERAPEUTICS, INC.	3 years
Chris Anderson	M	-	POIT BIOP	1 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Giovanni Caforio	M	59	BRISTOL-MYERS SQUIBB COMPANY	24 years
Charles A. Heimbold	M	-	BRISTOL-MYERS SQUIBB COMPANY	20 years
Jay C. Strum	M	-	G1 THERAPEUTICS, INC.	11 years
Mark Velleca	M	60	G1 THERAPEUTICS, INC.	9 years
Friedrich von Bohlen und Halbach	M	60	AGENNIX AG	-
Joe McCann	M	47	POIT BIOP	3 years
Jennifer Moses	F	49	G1 THERAPEUTICS, INC.	-
Seth A. Rudnick	M	75	G1 THERAPEUTICS, INC.	7 years
Christy Shaffer	M	66	G1 THERAPEUTICS, INC.	6 years
Neil Fleshner	M	60	POIT BIOP	3 years
Joseph Squicciarino	M	67	BRISTOL-MYERS SQUIBB COMPANY	22 years
Andrew Witty	M	59	G1 THERAPEUTICS, INC.	3 years
Brian Daniels	M	65	BRISTOL-MYERS SQUIBB COMPANY	14 years
Peter Kolchinsky	M	47	G1 THERAPEUTICS, INC.	2 years
John E. Elicker	M	64	BRISTOL-MYERS SQUIBB COMPANY	20 years
Torsten Hombeck	M	54	AGENNIX AG	4 years
Ari Shomair	M	-	POIT BIOP	-
Margaret Gilmour	F	64	POIT BIOP	-
Jeff Macdonald	M	-	G1 THERAPEUTICS, INC.	3 years
David Lubner	M	60	POIT BIOP	2 years
Steven Simonson	M	65	AGENNIX AG	1 years
Bridget Martell	M	58	POIT BIOP	-
Jason Haddock	M	54	BRISTOL-MYERS SQUIBB COMPANY	14 years
Tyrell J. Rivers	M	51	G1 THERAPEUTICS, INC.	1 years
James Hanson	M	52	G1 THERAPEUTICS, INC.	-
Justyna Kelly	F	39	POIT BIOP	2 years
Gerald Hogue	M	66	POIT BIOP	2 years
William Demers	M	66	POIT BIOP	2 years
Timothy Sullivan	M	53	G1 THERAPEUTICS, INC.	1 years
Yael Margolin	M	70	POIT BIOP	2 years
Willie Deese	M	68	G1 THERAPEUTICS, INC.	4 years
Barry J. Wolfenson	M	57	BRISTOL-MYERS SQUIBB COMPANY	23 years
Timothy Meeker	M	77	BRISTOL-MYERS SQUIBB COMPANY	13 years
Jonathan Goodman	M	56	POIT BIOP	2 years
Gregory J. Mossinghoff	M	-	G1 THERAPEUTICS, INC.	3 years
Fred Eshelman	M	76	G1 THERAPEUTICS, INC.	6 years
Barry A. Labinger	M	60	BRISTOL-MYERS SQUIBB COMPANY	3 years
Fu-Min Su	M	-	BRISTOL-MYERS SQUIBB COMPANY	6 years
Andrew Shenker	M	69	BRISTOL-MYERS SQUIBB COMPANY	5 years
Bruce Wendel	M	70	BRISTOL-MYERS SQUIBB COMPANY	14 years
Thomas J. McKearn	M	75	BRISTOL-MYERS SQUIBB COMPANY	10 years
Ning Yan	M	-	BRISTOL-MYERS SQUIBB COMPANY	7 years
Susan Holmes	F	-	BRISTOL-MYERS SQUIBB COMPANY	3 years
Antoine Grouès	M	-	BRISTOL-MYERS SQUIBB COMPANY	-
Jaisim Shah	M	63	BRISTOL-MYERS SQUIBB COMPANY	3 years
Amit Rakhit	M	54	BRISTOL-MYERS SQUIBB COMPANY	10 years
Lynn H. Clark	F	66	BRISTOL-MYERS SQUIBB COMPANY	8 years
Arturo O. Araya	M	53	BRISTOL-MYERS SQUIBB COMPANY	3 years
David L. Zabor	M	69	BRISTOL-MYERS SQUIBB COMPANY	-
James G. Ham	M	74	BRISTOL-MYERS SQUIBB COMPANY	7 years
Dean Mitchell	M	68	BRISTOL-MYERS SQUIBB COMPANY	3 years
Wendy Dixon	M	68	BRISTOL-MYERS SQUIBB COMPANY	8 years
Stephen E. Bear	M	73	BRISTOL-MYERS SQUIBB COMPANY	7 years
Steven E. Benner	M	64	BRISTOL-MYERS SQUIBB COMPANY	7 years
Paul Herbert Chew	M	72	BRISTOL-MYERS SQUIBB COMPANY	9 years
Erik Harris	M	54	BRISTOL-MYERS SQUIBB COMPANY	2 years
Susan Mahony	M	59	BRISTOL-MYERS SQUIBB COMPANY	5 years
Roger Theodoredis	M	65	BRISTOL-MYERS SQUIBB COMPANY	3 years
David Apelian	M	59	BRISTOL-MYERS SQUIBB COMPANY	2 years
Peter Kiener	M	72	BRISTOL-MYERS SQUIBB COMPANY	18 years
Robert L. Simon	M	79	BRISTOL-MYERS SQUIBB COMPANY	13 years
Gary Dickinson	M	72	BRISTOL-MYERS SQUIBB COMPANY	4 years
David E. Martin	M	57	BRISTOL-MYERS SQUIBB COMPANY	2 years
Jane A. Kramer	F	68	BRISTOL-MYERS SQUIBB COMPANY	11 years
Timothy P. Cost	M	65	BRISTOL-MYERS SQUIBB COMPANY	5 years
Tamar Howson	F	75	BRISTOL-MYERS SQUIBB COMPANY	6 years
Kenneth E. Weg	M	85	BRISTOL-MYERS SQUIBB COMPANY	10 years
Andrew Bonfield	M	61	BRISTOL-MYERS SQUIBB COMPANY	5 years
Stephen Sadove	M	72	BRISTOL-MYERS SQUIBB COMPANY	10 years
Rebecca Taub	M	71	BRISTOL-MYERS SQUIBB COMPANY	3 years
Robert Peach	M	68	BRISTOL-MYERS SQUIBB COMPANY	9 years
Beth Anne Piper	M	-	BRISTOL-MYERS SQUIBB COMPANY	4 years
Charles M. Urbain	M	70	BRISTOL-MYERS SQUIBB COMPANY	14 years
Enrique Sendagorta Gomendio	M	-	BRISTOL-MYERS SQUIBB COMPANY	-
James E. Foley	M	-	BRISTOL-MYERS SQUIBB COMPANY	-
Patricia Bellinger	F	63	BRISTOL-MYERS SQUIBB COMPANY	5 years
Christine Poon	F	71	BRISTOL-MYERS SQUIBB COMPANY	3 years
Michael J. Howerton	M	72	BRISTOL-MYERS SQUIBB COMPANY	-

Statistics

Country	Connections	% of total
United States	97	97.00%
Germany	3	3.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections